NASDAQ:VTGN | ROE | Vistagen Therapeutics, Inc.

Complete source-backed roe history.

Available history
2000-03-31 to 2026-06-30
Data captured

Historical ROE

DateROE
2026-06-30-276.21%
2026-03-31-196.19%
2025-12-31-131.67%
2025-09-30-93.82%
2025-06-30-98.26%
2025-03-31-73.05%
2024-12-31-58.31%
2024-09-30-42.55%
2024-06-30-31.67%
2024-03-31-25.69%
2023-12-31-26.01%
2023-09-30-99.54%
2023-06-30-677.10%
2023-03-31-490.46%
2022-12-31-308.15%
2022-09-30-217.81%
2022-06-30-129.84%
2022-03-31-73.80%
2021-12-31-46.62%
2021-09-30-39.73%
2021-06-30-26.34%
2021-03-31-19.50%
2020-12-31-15.98%
2020-09-30-370.69%
2020-06-30315.25%
2020-03-31362.59%
2019-12-31381.17%
2019-09-30674.47%
2019-06-30-1635.19%
2019-03-31-347.55%
2018-12-31-1355.45%
2018-09-30-469.60%
2018-06-30-505.79%
2018-03-31-207.41%
2017-12-31-124.88%
2017-09-30744.77%
2017-06-301739.24%
2017-03-31-1665.39%
2016-12-31-626.15%
2016-09-30-384.54%
2016-06-30-319.08%
2016-03-311586.07%
2015-12-312811.74%
2015-09-303312.23%
2015-06-301355.83%
2015-03-3167.59%
2014-12-3153.36%
2014-09-3047.60%
2014-06-3050.07%
2014-03-3123.19%
2013-12-3142.10%
2013-09-3081.38%
2013-06-3091.01%
2013-03-31102.63%
2012-12-31115.55%
2012-09-30175.35%
2012-06-30184.97%
2012-03-31213.99%
2011-12-31266.76%
2011-09-30132.93%
2011-06-30154.43%
2011-03-3128.83%

Annual ROE

DateROE
2026-03-31-196.19%
2025-03-31-73.05%
2024-03-31-25.69%
2023-03-31-490.46%
2022-03-31-73.80%
2021-03-31-19.50%
2020-03-31362.59%
2019-03-31-347.55%
2018-03-31-207.41%
2017-03-31-1665.39%
2016-03-311586.07%
2015-03-3167.59%
2014-03-3123.19%
2013-03-31102.63%
2012-03-31213.99%
2011-03-3128.83%
2010-03-3115.66%
2009-03-3117.60%
2008-03-3124.57%
2007-03-3111.46%
2006-03-3110.74%
2005-03-317.35%
2004-03-3163.96%
2003-03-3110.16%
2002-03-3146.10%
2001-03-3172.04%
2000-03-3182.93%

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.